Future therapeutic options in food allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 12, 2003, Pages 1217-1223

  Eigenmann, P A ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Anti IgE antibodies; Cytokines; Food hypersensitivity; Herbal medicine; T lymphocytes; Treatment

Indexed keywords

ANTIALLERGIC AGENT; BETA GLOBULIN; CARRAGEENAN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CROMOGLYCATE DISODIUM; DNA VACCINE; HERBACEOUS AGENT; IMMUNOGLOBULIN E ANTIBODY; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; LIPOSOME; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEPOLIZUMAB; MONOCLONAL ANTIBODY; OMALIZUMAB; PEANUT EXTRACT; PLASMID DNA; POLYSACCHARIDE; RECOMBINANT INTERLEUKIN 12; UCB 35625; UNCLASSIFIED DRUG;

CHINESE HERB; CHINESE MEDICINE; CLINICAL TRIAL; DESENSITIZATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INFUSION; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INJECTION; MEDICINAL PLANT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PEANUT; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION;

ADULT; ANIMALS; CHILD; DOGS; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOTHERAPY; MICE; MODELS, ANIMAL; RATS;

EID: 0344393725     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00303.x     Document Type: Review

References (48)

1. BOCK SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987;79:683-688.
2. HIDE DW, GUYER BM. Cow milk intolerance in Isle of Wight infants. Br J Clin Prac 1983;37:285-287.
3. HOST A, HALKEN S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Allergy 1990;45:587-596.
4. JAKOBSSON I, LINDBERG T. A prospective study of cow's milk protein intolerance in Swedish infants. Acta Pediatr Scand 1979;68: 853-859.
5. SCHRANDER JJP, VAN DEN BOGART JPH, FORGET PP, SCHRANDER-STUMPEL CTRM, KUIJTEN RH, KESTER ADM. Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr 1993;152:640-644.
6. NIESTIJL JANSEN JJ, KARDINAAL AFM, HUIJBERS GH, VLIEG-BOERSTRA BJ, MARTENS BPM, OCKHUIZEN T. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994;93:446-456.
7. YOUNG E, STONEHAM MD, PETRUCKEVITCH A, BARTON J, RONA R. A population study of food intolerance. Lancet 1994;343:1127-1130.
8. YOCUM MW, BUTTERFIELD JH, KLEIN JS, VOLCHECK GW, SCHROEDER DR, SILVERSTEIN MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999;104:452-456.
9. BOCK SA, MUNOZ-FURLONG A, SAMPSON HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-193.
10. EIGENMANN PA. Food allergy: a long way to safe processed foods. Allergy 2001;56:1112-1113.
11. JOHANSSON SG, HOURIHANE JO, BOUSQUET J, BRUIJNZEEL-KOOMEN C, DREBORG S, HAAHTELA T et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
12. SAMPSON HA, ANDERSON JA. Summary and recommendations: classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr 2000;30(Suppl.):S87- S94.
13. BAUER A, EKANAYAKE MS, WIGGER-ALBERTI W, ELSNER P. Oral rush desensitization to milk. Allergy 1999;54:894-895.
14. PATRIARCA G, SCHIAVINO D, NUCERA E, SCHINCO G, MILANI A, GASBARRINI GB. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998;45:52-58.
15. GOLDSTEIN GB, HEINER DC. Clinical and immunological perspectives in food sensitivity. A review. J Allergy 1970;46:270-291.
16. WUTHRICH B. Oral desensitization with cow's milk in cow's milk allergy. Pro! Monogr Allergy 1996;32:236-240.
17. PATRIARCA G, NUCERA E, RONCALLO C, POLLASTRINI E, BARTOLOZZI F, DE PASQUALE T et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003;17:459-465.
18. LOMBARDI C, GARGIONI S, MELCHIORRE A, TIRI A, FALAGIANI P, CANONICA GW et al. Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study. Allergy 2001;56:989-992.
19. BURKS W. Peanut allergy: a growing phenomenon. J Clin Invest 2003;111:950-952.
20. OPPENHEIMER JJ, NELSON HS, BOCK SA, CHRISTENSEN F, LEUNG DYM. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992;90:256-262.
21. NELSON HS, LAHR J, RULE R, BOCK A, LEUNG D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:744-751.
22. SEN M, KOPPER R, PONS L, ABRAHAM EC, BURKS AW, BANNON GA. Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. J Immunol 2002;169:882-887.
23. BANNON GA, COCKRELL G, CONNAUGHTON C, WEST CM, HELM R, STANLEY JS et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 2001;124:70-72.
24. RABJOHN P, WEST CM, CONNAUGHTON C, SAMPSON HA, HELM RM, BURKS AW et al. Modification of peanut allergen Ara h 3: effects on IgE binding and T cell stimulation. Int Arch Allergy Immunol 2002;128:15-23.
25. BUSINCO L, BENINCORI N, NINI G, BUSINCO E, CANTANI A, DE ANGELIS M. Double-blind crossover trial with oral sodium cromoglycate in children with atopic dermatitis due to food allergy. Ann Allergy 1986;57:433-438.
26. BURKS AW, SAMPSON HA. Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity. J Allergy Clin Immunol 1988;81: 417-423.
27. VAZ GA, TAN LK, GERRARD JW. Oral cromoglycate in treatment of adverse reactions to foods. Lancet 1978;1:1066-1068.
28. HERRMANN D, HENZGEN M, FRANK E, RUDESCHKO O, JAGER L. Effect of hyposensitization for tree pollinosis on associated apple allergy. J Investig Allergol Clin Immunol 1995;5:259-267.
29. KELSO JM, JONES RT, TELLEZ R, YUNGINGER JW. Oral allergy syndrome successfully treated with pollen immunotherapy. Ann Allergy Asthma Immunol 1995;74:391-396.
30. ASERO R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998;28:1368-1373.
31. LEUNG DY, SAMPSON HA, YUNGINGER JW, BURKS JR AW, SCHNEIDER LC, WORTEL CH et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003;348:986-993.
32. MAJAMAA H, ISOLAURI E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-185.
33. TEUBER SS, DEL VAL G, MORIGASAKI S, JUNG HR, EISELE PH, FRICK OL et al. The atopic dog as a model of peanut and tree nut food allergy. J Allergy Clin Immunol 2002;110:921-927.
34. LI XM, SCHOFIELD BH, HUANG CK, KLEINER GI, SAMPSON HA. A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999;103:206-214.
35. LI XM, SEREBRISKY D, LEE SY, HUANG CK, BARDINA L, SCHOFIELD BH et al. A murine model of peanut anaphylaxis: T-and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000;106: 150-158.
36. ATKINSON HA, MILLER K. Assessment of the brown Norway rat as a suitable model for the investigation of food allergy. Toxicology 1994;91:281-288.
37. SNIDER DP, MARSHALL JS, PERDUE MH, LIANG H. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein antigen and cholera toxin. J Immunol 1994;153:647-657.
38. FROSSARD CP, HAUSER C, EIGENMANN PA. Oral carrageenan induces antigen-dependent oral tolerance: prevention of anaphylaxis and induction of lymphocyte anergy in a murine model of food allergy. Pediatr Res 2001;49:417-422.
39. LI X, HUANG CK, SCHOFIELD BH, BURKS AW, BANNON GA, KIM KH et al. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol 1999;162:3045-3052.
40. LI XM, ZHANG TF, HUANG CK, SRIVASTAVA K, TEPER AA, ZHANG L et al. Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 2001;108:639-646.
41. LEE SY, HUANG CK, ZHANG TF, SCHOFIELD BH, BURKS AW, BANNON GA et al. Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin Immunol 2001;101:220-228.
42. ROY K, MAO HQ, HUANG SK, LEONG KW. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5: 387-391.
43. BORISH L, NELSON HS, CORREN J, BENSCH G, BUSSE W, WHITMORE J et al. Phase I/II study of recombinant interleukin-4 receptor (IL-4R) in adult patients with moderate asthma. J Allergy Clinical Immunol 2000;105:S282.
44. LECKIE MJ, TEN BRINKE A, KHAN J, DIAMANT Z, O'CONNOR BJ, WALLS CM et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
45. HESTERBERG PE, WINSOR-HINES D, BRISKIN MJ, SOLER-FERRAN D, MERRILL C, MACKAY CR et al. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology 1996;111:1373-1380.
46. WHITCUP SM, CHAN CC, KOZHICH AT, MAGONE MT. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clin Immunol 1999;93:107-113.
47. HEATH H, QIN S, RAO P, WU L, LAROSA G, KASSAM N et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-184.
48. HARBOUR R, MILLER J. A new system for grading recommendations in evidence based guidelines. Br Med J 2001;323:334-336.